Loading the security overview…
Where the tokens are
| Quarter | EPS | EPS vs year ago | Revenue | Revenue vs year ago |
|---|---|---|---|---|
| Q4 FY20ended Dec 31, 2020 | −$6.45 | — | — | — |
| Q3 FY20ended Sep 30, 2020 | −$2.40 | — | — | — |
| Q1 FY20ended Mar 31, 2020 | −$1.05 | — | — | — |
| Q4 FY19ended Dec 31, 2019 | −$4.65 | — | — | — |
| Q3 FY19ended Sep 30, 2019 | −$3.45 | — | — | — |
| Q1 FY19ended Mar 31, 2019 | −$10.35 | — | — | — |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss.
Figures describe Enlivex Therapeutics shares, not any token. From Massive's standardised financials and the earnings calendar.